Ted M. Dawson

Advisor at Hopstem

Dr. Ted Dawson has received funding support of more than 76 million US dollars from the United States National Institutes of Health and other foundations, has published 445 top academic articles, with an H index of 145, and a total of more than 85,000 citations.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Hopstem

Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.


Headquarters

Hangzhou, China

Employees

11-50

Links